Natalizumab and fingolimod: insight into their relative efficacies in clinical practice

Mult Scler. 2014 Sep;20(10):1280-1. doi: 10.1177/1352458514535283.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antibodies, Viral / blood*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • JC Virus / immunology*
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Propylene Glycols / therapeutic use*
  • Serologic Tests*
  • Sphingosine / analogs & derivatives*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Viral
  • Immunosuppressive Agents
  • Propylene Glycols
  • Sphingosine